Correlation Between C4 Therapeutics and Shattuck Labs
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Shattuck Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Shattuck Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Shattuck Labs, you can compare the effects of market volatilities on C4 Therapeutics and Shattuck Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Shattuck Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Shattuck Labs.
Diversification Opportunities for C4 Therapeutics and Shattuck Labs
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between CCCC and Shattuck is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Shattuck Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shattuck Labs and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Shattuck Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shattuck Labs has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Shattuck Labs go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Shattuck Labs
Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Shattuck Labs. But the stock apears to be less risky and, when comparing its historical volatility, C4 Therapeutics is 1.63 times less risky than Shattuck Labs. The stock trades about -0.23 of its potential returns per unit of risk. The Shattuck Labs is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 117.00 in Shattuck Labs on December 29, 2024 and sell it today you would lose (3.00) from holding Shattuck Labs or give up 2.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
C4 Therapeutics vs. Shattuck Labs
Performance |
Timeline |
C4 Therapeutics |
Shattuck Labs |
C4 Therapeutics and Shattuck Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with C4 Therapeutics and Shattuck Labs
The main advantage of trading using opposite C4 Therapeutics and Shattuck Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Shattuck Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shattuck Labs will offset losses from the drop in Shattuck Labs' long position.C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
Shattuck Labs vs. C4 Therapeutics | Shattuck Labs vs. Prelude Therapeutics | Shattuck Labs vs. Monte Rosa Therapeutics | Shattuck Labs vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stocks Directory Find actively traded stocks across global markets |